<DOC>
	<DOCNO>NCT01964885</DOCNO>
	<brief_summary>IQP-AS-105 , food supplement derive garlic ( Allium sativum ) . The objective study evaluate possibility clinical use IQP-AS-105 preventive medicine , base ability enhance immune system response</brief_summary>
	<brief_title>Benefit Tolerability IQP-AS-105 Reducing Susceptibility Upper Respiratory Tract Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Disease Susceptibility</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Common Cold</mesh_term>
	<criteria>age 1870 year increase risk infection least 4 cold episode within 12 month commitment adhere accustom diet physical activity woman childbearing potential agree use appropriate birth control method write consent subject participate prerequisite study participation acute / chronic upper airway disease chronic cough origin acute / chronic low airway disease allergic reaction may influence study outcome ( e.g . acute/chronic rhinitis ) history nasal reconstructive surgery presence nasal ulcer nasal polyp severe nasal septum deviation condition could cause nasal obstruction congenital acquire immunodeficiency disease ( e.g . HIV infection ) severe organ systemic disease body temperature 37.5Â°C suspected swine flu influenza vaccination influenza swine flu within 3 month prior study start stomach/gastrointestinal disease sleep disorder psychiatric disorder know sensitivity ingredient investigational product intake product may influence study outcome within last 14 day prior study start study analgesic , antibiotic decongestant nose drops/spray , unless use rescue medication pregnancy nurse alcohol / drug abuse simultaneous participation another clinical trial participation clinical trial within last 30 day insufficient compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>